• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

血清高密度脂蛋白部分中 S1P、二氢-S1P 和 C24:1-神经酰胺的水平与缺血性心脏病的发生呈负相关。

S1P, dihydro-S1P and C24:1-ceramide levels in the HDL-containing fraction of serum inversely correlate with occurrence of ischemic heart disease.

机构信息

Department of Regenerative Medicine and Cell Biology, Medical University of South Carolina, Charleston, SC 29425, USA.

出版信息

Lipids Health Dis. 2011 May 9;10:70. doi: 10.1186/1476-511X-10-70.

DOI:10.1186/1476-511X-10-70
PMID:21554699
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3116499/
Abstract

BACKGROUND

The lysosphingolipid sphingosine 1-phosphate (S1P) is carried in the blood in association with lipoproteins, predominantly high density lipoproteins (HDL). Emerging evidence suggests that many of the effects of HDL on cardiovascular function may be attributable to its S1P cargo.

METHODS

Here we have evaluated how levels of S1P and related sphingolipids in an HDL-containing fraction of human serum correlate with occurrence of ischemic heart disease (IHD). To accomplish this we used liquid chromatography-mass spectrometry to measure S1P levels in the HDL-containing fraction of serum (depleted of LDL and VLDL) from 204 subjects in the Copenhagen City Heart Study (CCHS). The study group consisted of individuals having high serum HDL cholesterol (HDL-C) (females:≥ 73.5 mg/dL; males:≥ 61.9 mg/dL) and verified IHD; subjects with high HDL-C and no IHD; individuals with low HDL-C (females:≤ 38.7 mg/dL; males:≤ 34.1 mg/dL) and IHD, and subjects with low HDL-C and no IHD.

RESULTS

The results show a highly significant inverse relationship between the level of S1P in the HDL-containing fraction of serum and the occurrence of IHD. Furthermore, an inverse relationship with IHD was also observed for two other sphingolipids, dihydro-S1P and C24:1-ceramide, in the HDL-containing fraction of serum. Additionally, we demonstrated that the amount of S1P on HDL correlates with the magnitude of HDL-induced endothelial cell barrier signaling.

CONCLUSIONS

These findings indicate that compositional differences of sphingolipids in the HDL-containing fraction of human serum are related to the occurrence of IHD, and may contribute to the putative protective role of HDL in IHD.

摘要

背景

溶血磷脂酰基 1-磷酸(S1P)与脂蛋白结合存在于血液中,主要与高密度脂蛋白(HDL)结合。新出现的证据表明,HDL 对心血管功能的许多影响可能归因于其 S1P 携带物。

方法

我们在这里评估了人血清中含 HDL 部分的 S1P 及其相关鞘脂的水平与缺血性心脏病(IHD)的发生有何关联。为了实现这一目标,我们使用液相色谱-质谱法测量了哥本哈根城市心脏研究(CCHS)204 名受试者血清中含 HDL 部分(不含 LDL 和 VLDL)的 S1P 水平。研究组由血清 HDL 胆固醇(HDL-C)水平较高的个体组成(女性:≥73.5mg/dL;男性:≥61.9mg/dL),并经证实患有 IHD;HDL-C 水平较高且无 IHD 的受试者;血清 HDL-C 水平较低的个体(女性:≤38.7mg/dL;男性:≤34.1mg/dL)和患有 IHD,以及血清 HDL-C 水平较低且无 IHD 的个体。

结果

结果表明,血清中含 HDL 部分的 S1P 水平与 IHD 的发生之间存在高度显著的负相关关系。此外,血清中含 HDL 部分的两种其他鞘脂,二氢-S1P 和 C24:1-神经酰胺,也与 IHD 呈负相关关系。此外,我们还证明了 HDL 上的 S1P 量与 HDL 诱导的内皮细胞屏障信号的幅度相关。

结论

这些发现表明,人血清中含 HDL 部分的鞘脂的组成差异与 IHD 的发生有关,并可能有助于 HDL 在 IHD 中的假定保护作用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7453/3116499/8629a73a6a91/1476-511X-10-70-5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7453/3116499/b330ff604ec3/1476-511X-10-70-1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7453/3116499/c80f203e12de/1476-511X-10-70-2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7453/3116499/a2eb10f97795/1476-511X-10-70-3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7453/3116499/4eee7a7a4f16/1476-511X-10-70-4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7453/3116499/8629a73a6a91/1476-511X-10-70-5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7453/3116499/b330ff604ec3/1476-511X-10-70-1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7453/3116499/c80f203e12de/1476-511X-10-70-2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7453/3116499/a2eb10f97795/1476-511X-10-70-3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7453/3116499/4eee7a7a4f16/1476-511X-10-70-4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7453/3116499/8629a73a6a91/1476-511X-10-70-5.jpg

相似文献

1
S1P, dihydro-S1P and C24:1-ceramide levels in the HDL-containing fraction of serum inversely correlate with occurrence of ischemic heart disease.血清高密度脂蛋白部分中 S1P、二氢-S1P 和 C24:1-神经酰胺的水平与缺血性心脏病的发生呈负相关。
Lipids Health Dis. 2011 May 9;10:70. doi: 10.1186/1476-511X-10-70.
2
A Shift in ApoM/S1P Between HDL-Particles in Women With Type 1 Diabetes Mellitus Is Associated With Impaired Anti-Inflammatory Effects of the ApoM/S1P Complex.1型糖尿病女性患者高密度脂蛋白颗粒中载脂蛋白M/鞘氨醇-1-磷酸的变化与载脂蛋白M/鞘氨醇-1-磷酸复合物抗炎作用受损有关。
Arterioscler Thromb Vasc Biol. 2017 Jun;37(6):1194-1205. doi: 10.1161/ATVBAHA.117.309275. Epub 2017 Apr 6.
3
Correlation of high density lipoprotein (HDL)-associated sphingosine 1-phosphate with serum levels of HDL-cholesterol and apolipoproteins.高密度脂蛋白(HDL)相关的1-磷酸鞘氨醇与血清HDL胆固醇及载脂蛋白水平的相关性。
Atherosclerosis. 2005 Jan;178(1):199-205. doi: 10.1016/j.atherosclerosis.2004.08.024.
4
Dihydro-sphingosine 1-phosphate interacts with carrier proteins in a manner distinct from that of sphingosine 1-phosphate.二氢神经酰胺 1-磷酸以不同于神经鞘氨醇 1-磷酸的方式与载体蛋白相互作用。
Biosci Rep. 2018 Oct 31;38(5). doi: 10.1042/BSR20181288.
5
Significant abnormalities of the HDL phosphosphingolipidome in type 1 diabetes despite normal HDL cholesterol concentration.1 型糖尿病患者尽管 HDL 胆固醇浓度正常,但 HDL 磷磷脂组显著异常。
Atherosclerosis. 2015 Aug;241(2):752-60. doi: 10.1016/j.atherosclerosis.2015.06.040. Epub 2015 Jun 29.
6
Plasma sphingosine-1-phosphate concentrations are associated with systolic heart failure in patients with ischemic heart disease.血浆中1-磷酸鞘氨醇浓度与缺血性心脏病患者的收缩性心力衰竭有关。
J Mol Cell Cardiol. 2017 Sep;110:35-37. doi: 10.1016/j.yjmcc.2017.07.004. Epub 2017 Jul 12.
7
Arteriovenous Sphingosine-1-Phosphate Differences Across Selected Organs of the Rat.大鼠特定器官间动静脉鞘氨醇-1-磷酸的差异
Cell Physiol Biochem. 2018;45(1):67-77. doi: 10.1159/000486223. Epub 2017 Dec 22.
8
Serum-Sphingosine-1-Phosphate Concentrations Are Inversely Associated with Atherosclerotic Diseases in Humans.血清鞘氨醇 -1- 磷酸浓度与人类动脉粥样硬化疾病呈负相关。
PLoS One. 2016 Dec 14;11(12):e0168302. doi: 10.1371/journal.pone.0168302. eCollection 2016.
9
Regulation of Serum Sphingolipids in Andean Children Born and Living at High Altitude (3775 m).安第斯山区(海拔 3775 米)出生和生活的儿童血清神经酰胺的调节。
Int J Mol Sci. 2019 Jun 11;20(11):2835. doi: 10.3390/ijms20112835.
10
High-density lipoprotein of patients with type 2 diabetes mellitus upregulates cyclooxgenase-2 expression and prostacyclin I-2 release in endothelial cells: relationship with HDL-associated sphingosine-1-phosphate.2 型糖尿病患者的高密度脂蛋白上调内皮细胞中环氧化酶-2 的表达和前列环素 I-2 的释放:与高密度脂蛋白相关的鞘氨醇-1-磷酸的关系。
Cardiovasc Diabetol. 2013 Jan 30;12:27. doi: 10.1186/1475-2840-12-27.

引用本文的文献

1
Do circulating sphingolipid species correlate with age? A study in a normoglycemic biracial population.循环鞘脂种类与年龄相关吗?一项针对血糖正常的双种族人群的研究。
Biogerontology. 2025 May 5;26(3):106. doi: 10.1007/s10522-025-10244-9.
2
Apolipoprotein and sphingolipid measurements: Can be used in the clinical practice of atrial fibrillation diagnosing and evaluating the cryoablation effectiveness?载脂蛋白和鞘脂测量:可用于心房颤动诊断及评估冷冻消融疗效的临床实践吗?
PLoS One. 2025 Mar 4;20(3):e0315905. doi: 10.1371/journal.pone.0315905. eCollection 2025.
3
Inverse relationship between circulating sphingosine-1-phosphate and precursor species and coronary artery calcification score in type 2 diabetes.

本文引用的文献

1
Lipoprotein isolation and analysis from serum by preparative ultracentrifugation.通过制备性超速离心从血清中分离和分析脂蛋白。
Methods Mol Med. 2001;52:27-35. doi: 10.1385/1-59259-073-X:27.
2
Sphingosine 1-phosphate levels in plasma and HDL are altered in coronary artery disease.血浆和高密度脂蛋白中的神经鞘氨醇 1-磷酸水平在冠状动脉疾病中发生改变。
Basic Res Cardiol. 2010 Nov;105(6):821-32. doi: 10.1007/s00395-010-0112-5. Epub 2010 Jul 21.
3
High pre-beta1 HDL concentrations and low lecithin: cholesterol acyltransferase activities are strong positive risk markers for ischemic heart disease and independent of HDL-cholesterol.
2型糖尿病患者循环中鞘氨醇-1-磷酸及其前体物质与冠状动脉钙化评分之间的负相关关系。
Cardiovasc Diabetol. 2025 Feb 21;24(1):85. doi: 10.1186/s12933-025-02624-9.
4
Unravelling neuronal and glial differences in ceramide composition, synthesis, and sensitivity to toxicity.解析神经细胞和神经胶质细胞在神经酰胺组成、合成和对毒性敏感性方面的差异。
Commun Biol. 2024 Nov 30;7(1):1597. doi: 10.1038/s42003-024-07231-0.
5
High-Density Lipoprotein in Metabolic Disorders and Beyond: An Exciting New World Full of Challenges and Opportunities.代谢紊乱及其他领域中的高密度脂蛋白:一个充满挑战与机遇的全新激动人心的世界。
Pharmaceuticals (Basel). 2023 Jun 8;16(6):855. doi: 10.3390/ph16060855.
6
Sphingolipids and Atherosclerosis: The Dual Role of Ceramide and Sphingosine-1-Phosphate.鞘脂与动脉粥样硬化:神经酰胺和1-磷酸鞘氨醇的双重作用
Antioxidants (Basel). 2023 Jan 6;12(1):143. doi: 10.3390/antiox12010143.
7
Cord blood sphingolipids are associated with atopic dermatitis and wheeze in the first year of life.脐带血鞘脂与生命第一年的特应性皮炎和喘息有关。
J Allergy Clin Immunol Glob. 2022 Aug;1(3):162-171. doi: 10.1016/j.jacig.2022.03.002. Epub 2022 Apr 7.
8
Biogeographic and disease-specific alterations in epidermal lipid composition and single-cell analysis of acral keratinocytes.表皮脂质组成的生物地理和疾病特异性改变及肢端角质形成细胞的单细胞分析。
JCI Insight. 2022 Aug 22;7(16):e159762. doi: 10.1172/jci.insight.159762.
9
HDL and Lipid Metabolism.高密度脂蛋白与脂代谢。
Adv Exp Med Biol. 2022;1377:49-61. doi: 10.1007/978-981-19-1592-5_4.
10
HDL Structure.高密度脂蛋白结构。
Adv Exp Med Biol. 2022;1377:1-11. doi: 10.1007/978-981-19-1592-5_1.
高预-β1 高密度脂蛋白浓度和低卵磷脂:胆固醇酰基转移酶活性是缺血性心脏病的强烈阳性风险标志物,且独立于高密度脂蛋白胆固醇。
Clin Chem. 2010 Jul;56(7):1128-37. doi: 10.1373/clinchem.2009.139931. Epub 2010 May 28.
4
Sphingosine-1-phosphate in the plasma compartment regulates basal and inflammation-induced vascular leak in mice.血浆中的1-磷酸鞘氨醇调节小鼠的基础血管渗漏和炎症诱导的血管渗漏。
J Clin Invest. 2009 Jul;119(7):1871-9. doi: 10.1172/jci38575.
5
Sphingosine-1-phosphate as a mediator of high-density lipoprotein effects in cardiovascular protection.鞘氨醇-1-磷酸作为高密度脂蛋白在心血管保护作用中的介质。
Cardiovasc Res. 2009 May 1;82(2):201-11. doi: 10.1093/cvr/cvp070. Epub 2009 Feb 20.
6
Hepatic lipase, genetically elevated high-density lipoprotein, and risk of ischemic cardiovascular disease.肝脂肪酶、遗传性高密度脂蛋白升高与缺血性心血管疾病风险
J Clin Endocrinol Metab. 2009 Apr;94(4):1264-73. doi: 10.1210/jc.2008-1342. Epub 2008 Dec 16.
7
High density lipoprotein-associated sphingosine 1-phosphate promotes endothelial barrier function.高密度脂蛋白相关的1-磷酸鞘氨醇可促进内皮屏障功能。
J Biol Chem. 2008 Sep 5;283(36):25074-81. doi: 10.1074/jbc.M801214200. Epub 2008 Jul 7.
8
Association of loss-of-function mutations in the ABCA1 gene with high-density lipoprotein cholesterol levels and risk of ischemic heart disease.ABCA1基因功能丧失性突变与高密度脂蛋白胆固醇水平及缺血性心脏病风险的关联
JAMA. 2008 Jun 4;299(21):2524-32. doi: 10.1001/jama.299.21.2524.
9
European guidelines on cardiovascular disease prevention in clinical practice: executive summary.欧洲临床实践中心血管疾病预防指南:执行摘要
Atherosclerosis. 2007 Sep;194(1):1-45. doi: 10.1016/j.atherosclerosis.2007.08.024. Epub 2007 Sep 18.
10
HDL serves as a S1P signaling platform mediating a multitude of cardiovascular effects.高密度脂蛋白作为一个1-磷酸鞘氨醇信号平台,介导多种心血管效应。
J Lipid Res. 2007 Nov;48(11):2325-33. doi: 10.1194/jlr.R700011-JLR200. Epub 2007 Aug 13.